Building up the infrastructure for future pandemic preparedness: Frontiers in rapid raw material production
With the world facing threats from new and emerging infectious diseases, the ability to rapidly ramp up production of essential…
With the world facing threats from new and emerging infectious diseases, the ability to rapidly ramp up production of essential…
The latest webinar from EMIS, a leading healthcare technology provider, showcased its Pathway platform—a robust tool designed to improve the…
Clinical trials are the testing ground for new therapies. Ensuring the supply chains supporting these therapies remain robust is a…
As smaller, leaner organisations that must utilise resources carefully, biotechs face unique challenges as they enter clinical trials. These challenges…
Buffer management is a fundamental yet often neglected area of biopharmaceutical production. The demand for highly flexible multi-product systems is…
The pharmaceutical industry is currently experiencing a surge in novel drug candidates. These new drug approvals are leading to a…
We’ve all seen the statistics. Drug development has a scarily high attrition rate, with approximately 90% of candidates falling short.…
PACE is an innovative multi-product modular automation line. This disruptive technology is making waves by creating a more agile and…
Climate change’s escalating impact is reshaping the infectious disease landscape in pervasive and profound ways. Rising temperatures are expanding the…
Recent research from GlobalData analyzed the Net Zero strategies of the world’s top 18 pharmaceutical companies by revenue. All of…